2019-nCoV Novel Coronavirus Rapid Tests is Ready for Fighting the Virus !
February 07,2020 (Edit)
On Feb 7th, 2020, the type testing reports of 2019 Novel Coronavirus Antigen Detection Reagent (Immunochromatographic Method) and 2019 Novel Coronavirus Antibody Detection Reagent (Immunochromatographic Method) newly developed by Guangzhou Wondfo Biotech Co.,Ltd. (Stock Code: 300482) successfully issued by Guangdong Province Medical Devices Quality Surveillance and Test Institute, and it was entitled to further process.
 
2019 Novel Coronavirus Antigen Detection Reagent (Immunochromatography) can be used for the qualitative detection of coronavirus 2019-nCoV antigen in throat swabs and lower respiratory tract samples. It can help the diagnosis of novel coronavirus,providing evidence-based approaches for healthcare professionals to identify the infected patients, so that the proper precautions and restrictions can be implemented as soon as possible for better controlling the spreading of the virus.
 
2019 Novel Coronavirus Antibody Detection Reagent (Immunochromatography)can be used for the qualitative detection of 2019-nCoV antibodies in human serum, plasma, and whole blood samples. This rapid test is good for the first step screening of the suspected infected patients.
 



We strive for excellence to safeguard everyone’s health, and fight against the epidemic!